Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoru Yamasaki

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|November 3, 2010
[Role of zinc for mast cell degranulation]Keigo Nishida, Satoru Yamasaki, Toshio Hirano
Frontiers in Immunology|February 16, 2024
Tumor epitope spreading by a novel multivalent therapeutic cellular vaccine targeting cancer antigens to invariant NKT-triggered dendritic cells <i>in situ</i>Satoru Yamasaki, Kanako Shimizu, Shin-Ichiro Fujii
Clinical Calcium|October 30, 2012
[Zinc signaling : a novel regulatory system on bone homeostasis, and immune and allergic responses]Toshiyuki Fukada, Keigo Nishida, Satoru Yamasaki, et al.
Inflammation and Regeneration|November 29, 2022
Association of cellular immunity with severity of COVID-19 from the perspective of antigen-specific memory T cell responses and cross-reactivityShin-Ichiro Fujii, Satoru Yamasaki, Tomonori Iyoda, et al.
Frontiers in Immunology|June 20, 2018
Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell ResponsesShin-Ichiro Fujii, Satoru Yamasaki, Yusuke Sato, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|June 11, 2011
Zinc homeostasis and signaling in health and diseases: Zinc signalingToshiyuki Fukada, Satoru Yamasaki, Keigo Nishida, et al.
International Immunology|June 26, 2018
Immune suppression and reversal of the suppressive tumor microenvironmentKanako Shimizu, Tomonori Iyoda, Masahiro Okada, et al.
Biomolecules|February 25, 2023
Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting CancerTomonori Iyoda, Satoru Yamasaki, Shogo Ueda, et al.
Molecular Therapy. Methods & Clinical Development|June 26, 2023
Detection of mutant antigen-specific T cell receptors against multiple myeloma for T cell engineeringMasahiro Okada, Kanako Shimizu, Hiroshi Nakazato, et al.
Oncogene|March 12, 2003
Gab1 is required for EGF receptor signaling and the transformation by activated ErbB2Satoru Yamasaki, Keigo Nishida, Yuichi Yoshida, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|November 3, 2010
[Role of zinc for mast cell degranulation]Keigo Nishida, Satoru Yamasaki, Toshio Hirano
Frontiers in Immunology|February 16, 2024
Tumor epitope spreading by a novel multivalent therapeutic cellular vaccine targeting cancer antigens to invariant NKT-triggered dendritic cells <i>in situ</i>Satoru Yamasaki, Kanako Shimizu, Shin-Ichiro Fujii
Clinical Calcium|October 30, 2012
[Zinc signaling : a novel regulatory system on bone homeostasis, and immune and allergic responses]Toshiyuki Fukada, Keigo Nishida, Satoru Yamasaki, et al.
Inflammation and Regeneration|November 29, 2022
Association of cellular immunity with severity of COVID-19 from the perspective of antigen-specific memory T cell responses and cross-reactivityShin-Ichiro Fujii, Satoru Yamasaki, Tomonori Iyoda, et al.
Frontiers in Immunology|June 20, 2018
Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell ResponsesShin-Ichiro Fujii, Satoru Yamasaki, Yusuke Sato, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|June 11, 2011
Zinc homeostasis and signaling in health and diseases: Zinc signalingToshiyuki Fukada, Satoru Yamasaki, Keigo Nishida, et al.
International Immunology|June 26, 2018
Immune suppression and reversal of the suppressive tumor microenvironmentKanako Shimizu, Tomonori Iyoda, Masahiro Okada, et al.
Biomolecules|February 25, 2023
Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting CancerTomonori Iyoda, Satoru Yamasaki, Shogo Ueda, et al.
Molecular Therapy. Methods & Clinical Development|June 26, 2023
Detection of mutant antigen-specific T cell receptors against multiple myeloma for T cell engineeringMasahiro Okada, Kanako Shimizu, Hiroshi Nakazato, et al.
Oncogene|March 12, 2003
Gab1 is required for EGF receptor signaling and the transformation by activated ErbB2Satoru Yamasaki, Keigo Nishida, Yuichi Yoshida, et al.
Pageof 5